Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings

This article has no abstract
Epistemonikos ID: c7f84ec1337a767d93df43058ac5acfe3a48b8d2
First added on: Feb 12, 2025